COVID-19 assistance on federal laboratory reagents – Round #2

The Public Health Agency of Canada has sent a second call for items and reagents for the public health laboratories

  • For loan:
    1. Thermofisher Kingfisher Flex Purification Systems (automated nucleic acid purification) with the 96- Deep Well head
    2. Associated plastic consumables (96-well plate blocks) would also be of interest
  1. For use:
    1. Laboratory grade Guanidine thiocyanate

As with ‘Round 1” please forward any items to:

Rita Finley (

Post-Doctoral Position Available – Concussion Research (Drs. Brian Benson and Sean Dukelow) – University of Calgary

A postdoctoral position is available immediately under the supervision of Drs. Brian Benson and Sean Dukelow at the Hotchkiss Brain Institute, University of Calgary. The work is funded by a Mitacs Accelerate Fellowship award in association with Own the Podium. The successful candidate will take advantage of working with high-performance national level athletes at risk of concussion and advanced diagnostic tools including robotic technology (Kinarm) that monitors sensory, motor and cognitive behaviour. The environment involves working with a number of clinicians and scientists with a significant interest in sport-related concussion.

Qualified Canadian applicants should have a PhD degree in Neuroscience or related disciplines with significant expertise in human neuroscience and knowledge of coding in Matlab. Excellent written and oral communication are required. A strong academic track record as measured by publications and is an asset.

About the University of Calgary

The University of Calgary is Canada’s leading next-generation university – a living, growing and youthful institution that embraces change and opportunity with a can-do attitude. Located in the nation’s most enterprising city, the university is making tremendous progress on its Eyes High journey to be recognized as one of Canada’s top five research universities, grounded in innovative learning and teaching and fully integrated with the community it both serves and leads. The University of Calgary inspires and supports discovery, creativity and innovation across all disciplines.

For more information, visit The University of Calgary recognizes that a diverse staff/faculty benefits and enriches the work, learning and research experiences of the entire campus and greater community. We are committed to removing barriers that have been historically encountered by some people in our society. We strive to recruit individuals who will further enhance our diversity and will support their professional success while they are here.

Contact information:

Please send a statement of interest, Curriculum Vitae and the names of at least two references to:

Dr. Sean Dukelow
Hotchkiss Brain Institute, University of Calgary

Public Health Agency of Canada – call for reagents for COVID19 testing

We have been made aware by some of our members that the Public Health Agency of Canada (PHAC) has sent out an urgent request for reagents, specifically RNA extraction reagents for COVID19 testing.  If you have such reagents in your laboratory that you could donate (view list below) please consider doing so. If the laboratories have materials that we could use and are not included in the list, feel free to let us know and we will share with the National Microbiology Laboratory and asses their current requirements.
The contact person at the PHAC is Rita Finley (  As this is a time-sensitive request please let her know directly what you have available. Continue reading

A study by Martin Lévesque and his team explains the role of dopaminergic neurons in hyperactivity and suggests a mechanism of action for Ritalin

Martin LévesqueRead a new article by Université Laval news on a discovery by Martin Lévesque’s team

Cellular cogs of hyperactivity uncovered – Study clarifies the role of dopaminergic neurons in hyperactivity and suggests a mechanism of action for Ritalin

The cellular mechanism uncovered by the researchers could explain the mode of action of Ritalin in humans. The drug is believed to block the reuptake of dopamine by neurons, thereby prolonging the effects of this neurotransmitter.

Although about one in 10 people will suffer from attention deficit hyperactivity disorder (ADHD) in their lifetime, the cellular causes of this health problem are still very poorly understood. A study published in Cell Reports by a team from Laval University’s CERVO Research Centre now sheds some light on the subject. The researchers were able to determine which type of neurons are involved in the development of hyperactivity in mice and the cellular mechanisms involved. This breakthrough suggests a plausible mode of action for Ritalin, a drug widely prescribed for ADHD, but whose mechanism of action is unknown. Continue reading

McGill researchers end decade-long search for mechanical pain sensor

Reza Sharif-Naeini, image from
Reza Sharif-Naeini

Discovery brings hope for novel pain treatment

Researchers at McGill University have discovered that a protein found in the membrane of our sensory neurons are involved in our capacity to feel mechanical pain, laying the foundation for the development of powerful new analgesic drugs.

The study, published in Cell, is the first to show that TACAN, a highly conserved protein among vertebrates whose function remained unclear, is in fact involved in detecting mechanical pain by converting mechanical pressures into electric signals. Continue reading

Pain hypersensitivity: problem at the pump

Yves De Koninck
Yves De Koninck

Pain hypersensitivity and many other diseases could be associated with a protein that acts as an ion pump in neurons.

The research team led by Yves De Koninck, at Université Laval’s Faculté de médecine and the CERVO Brain Research Centre had already targeted a protein called KCC2 as a key player in the mechanism leading to pain hypersensitivity.  A new study published in Nature Communications confirms confirms this lead and reinforces the idea that this protein could be a target of choice for the creation of a new class of analgesics to treat this problem that medicine is often powerless to address. Continue reading

The Canadian-IBRO School Offers Two Teaching Internships on Neuroscience Education and Research in Africa and Latin America.

COVID-19 UPDATE: Due to uncertainties related to the evolution of the COVID-19 pandemic, the Canadian IBRO School has been postponed to 2021.  New opportunities will be posted next year.


Deadline for applications: March 30, 2020

A unique opportunity for 2 senior neuroscience graduate students or postdocs, registered at a Canadian university, interested in helping to promote neuroscience education and research capacity in Africa and Latin America.

This internship program builds on the rich scientific and cultural diversity that the Canadian-IBRO School program has accumulated since its inception in 2006. Successful applicants will spend 3 ½-weeks in Montreal, from May 14 – June 7, 2020 at the 14th Canadian-IBRO School.

Who should apply?
A unique opportunity for 2 senior neuroscience Graduate Students or Postdoctoral Fellows, registered at a Canadian university, interested in helping to promote neuroscience education and research capacity in Africa and Latin America.

The two Canadian IBRO Trainee Interns will contribute to the teaching of graduate trainees from Latin America and Africa, and gain valuable insights into the challenges and opportunities of conducting research in countries with limited resources. The Interns will be advised on how to coordinate discussions and interact with talented students from diverse backgrounds who have English as a second language. In addition, the Interns will gain a deeper knowledge of Canada’s role in international development and in lessening the burden of neurological diseases in low- and middle-income countries.
For more details consult the following page.

Where & When
The internship will take place in Montreal from May 14 – June 7, 2020, and include participation in the annual meeting of the Canadian Association for Neuroscience (CAN). This program covers travel costs, meals, and accommodation.

How to apply
Applicants should complete the online application. Instructions are provided on this page:

Submit a brief (200 words) statement of how their interests align with this internship, an updated CV, and a letter of reference from their supervisor before March 30, 2020 to:

Dr. Ellis Cooper:

For further details, see

Neurologist – Southlake Regional Health Centre, Ontario

Life. Career. Balance.
At Southlake, we’ve created something special … A big city hospital that hasn’t lost its community heart. A place where teamwork is the norm and new leaders are continually discovered. An environment where you can put your skills to work today, while advancing towards your goals for tomorrow. A collegial workplace focused on achieving work-life balance.

If you are committed to excellence, passionate about making a difference, and looking for a place where your career can flourish, come join us.

Southlake has some of the highest staff and physician satisfaction scores in the province. The latest data by NRC Picker confirms that we are providing the premium practice environment that you deserve.

Newmarket is located in York Region, part of the Central LHIN, on the northern edge of the Greater Toronto Area, allowing easy access to city activities as well as a short distance to cottage country and ski resorts. Residents of York Region enjoy access to an array of real estate options and public and private schools, making the area a choice location for many young families.


We are seeking an additional Neurologist to meet the demands of our unprecedented regional growth, population demographics and Southlake’s expanding comprehensive regional cardiac, cancer and surgical programs. Inpatient consultations will be shared equally amongst members, which, at minimum, is 10 to 15 new patients per week, and outpatient office referrals for consultation are endless. With the high demand, the successful candidate will have a fully established practice within weeks.

Anticipated time commitment for hospital vs. office practice will depend largely on the interests of the successful candidate. There is opportunity to provide consulting services to patients with movement disorders, epilepsy, neuromuscular diseases and stroke. Remuneration is fee-for-service, with unlimited outpatient referrals. Southlake has full medical diagnostics, including two 64-slice CT scanners (7/24 for head scans), 2 MRIs, Peripheral and Cardiac Angiography, Ultrasound, Nuclear Medicine, and Doppler, as well as full inpatient laboratory services with access to EEG. Southlake is a premier practice destination with outstanding facilities and outcomes, and an unrelenting focus on quality.

Southlake is a Centre of Excellence with a full complement of subspecialty medical staff. Join our team of exceptional individuals who are providing leading-edge care for their patients and families. Candidates must hold, or be eligible to hold, an Independent licence with the College of Physicians and Surgeons of Ontario and be Royal College-certified in Neurology.

To join our team, please forward a letter of interest and your curriculum vitae to:

Michele Skerratt
Manager, Medical Affairs
Southlake Regional Health Centre
596 Davis Drive
Newmarket, ON L3Y 2P9

We thank everyone for their interest; however, only those selected for an interview will be contacted.

Posting end date 2020/03/24

New Principal Investigator position in addiction / mental health – CRCHUM in Montreal

Job description

The Research Center of the Center hospitalier de l’Université de Montréal (CRCHUM) and the Department of Psychiatry and Addictology of the Université de Montréal (UdeM) are seeking to recruit a principal investigator in brain imaging and / or artificial intelligence with an interest in clinical research in addiction and related mental health issues.

The new principal investigator will join a rich research environment with cutting-edge technologies and a highly stimulating learning institution. Competitive recruitment conditions will be offered according to the experience of the candidate. The position could start as early as fall 2020.


  • Establish and implement an innovative and productive research program in the field of brain imaging and/or artificial intelligence applied to addiction and psychiatric comorbidities, consistent with ongoing research activities at the CRCHUM;
  • Supervise graduate students,
  • Teach in programs of the Université de Montréal,
  • Contribute to the academic life of the CRCHUM and the University department,
  • Participate in the knowledge translation mandates of the CRCHUM and the Faculty of Medicine, in particular by disseminating research results.


  • The candidates must have a doctorate in clinical research, epidemiology / biostatistics, neuroscience or a related field, and have completed relevant postdoctoral training. Early or mid-career candidates are sought.
  • The candidates should have a competitive track record of publications in peer-reviewed journals, and have demonstrated their potential to obtain research grants from recognized funding agencies.
  • Applicants must demonstrate relevant imaging expertise (PET, MRI or others) applicable to interventional and translational research in the fields of addiction and mental health. Skills in deep learning or artificial intelligence will be considered assets.
  • Applicants should have a solid academic record, excellent skills in interdisciplinary collaboration and good teaching skills are prerequisites for this position.
  • Applicants will ultimately have to be able to function in French and English.

Those received by March 31, 2020 will be given priority consideration. A complete application will consist of a cover letter, a complete CV, a detailed research plan (3 pages limit) as well as three letters of support to be submitted separately by the referees by email, preferably in electronic format.

Contact information

Applications must be submitted electronically to

View a PDF version of this advertisement here 


Posting end date: 2020/03/31